Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 26 von 1011
World journal of gastroenterology : WJG, 2008-07, Vol.14 (28), p.4540-4545
2008
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Radiofrequency ablation as a treatment for hilar cholangiocarcinoma
Ist Teil von
  • World journal of gastroenterology : WJG, 2008-07, Vol.14 (28), p.4540-4545
Ort / Verlag
United States: Cancer Center of Sun Yat-Sen University, 651# Dong Feng Dong Road, Guangzhou 510060, Guangdong Province, China%Radiology Department, Centro Hospitalar Conde de Sao Januario (CHCSJ), Macau SAR CP3002, China
Erscheinungsjahr
2008
Quelle
Free E-Journal (出版社公開部分のみ)
Beschreibungen/Notizen
  • AIM: To explore the role of radio-frequency ablation (RFA) as a treatment for hilar cholangiocarcinoma. METHODS: Eleven patients with obstructive cholestasis underwent Computed Tomography (CT) examination, occupying lesions were observed in the hepatic hilar region in each patient. All lesions were confirmed as cholangioadenocarcinoma by biopsy and were classified as type Ⅲ or Ⅳ by percutaneous transhepatic cholangiography. Patients were treated with multiple electrodes RFA combined with other adjuvant therapy. The survival rate, change of CT attenuation coefficient of the tumor and tumor size were studied in these patients after RFA. RESULTS: In a follow-up CT scan one month after RFA, a size reduction of about 30% was observed in six masses, and two masses were reduced by about 20% in size, three of the eleven masses remained unchanged. In a follow-up CT scan 6 mo after RFA, all the masses were reduced in size (overall 35%), in which the most significant size reduction was 60%. The survival follow-up among these eleven cases was 18 mo in average. Ongoing follow-up showed that the longest survival case was 30 mo and the shortest case was 10 mo. CONCLUSION: RFA is a microinvasive and effective treatment for hilar cholangiocarcinoma.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX